Characterization of genetic loss-of-function of Fus in zebrafish

被引:18
|
作者
Lebedeva, Svetlana [1 ]
Domingues, Antonio M. de Jesus [1 ]
Butter, Falk [1 ]
Ketting, Rene F. [1 ]
机构
[1] Inst Mol Biol, Mainz, Germany
关键词
CRISPR-Cas9; Danio rerio; Fus; genetic knockout; morpholino; zebrafish; MOTOR-NEURON DEGENERATION; WILD-TYPE; TOXIC GAIN; ALS; PROTEINS; FUS/TLS; BINDING; MUTATIONS; TDP-43; DEFICIENCY;
D O I
10.1080/15476286.2016.1256532
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The RNA-binding protein FUS is implicated in transcription, alternative splicing of neuronal genes and DNA repair. Mutations in FUS have been linked to human neurodegenerative diseases such as ALS (amyotrophic lateral sclerosis). We genetically disrupted fus in zebrafish (Danio rerio) using the CRISPR-Cas9 system. The fus knockout animals are fertile and did not show any distinctive phenotype. Mutation of fus induces mild changes in gene expression on the transcriptome and proteome level in the adult brain. We observed a significant influence of genetic background on gene expression and 3UTR usage, which could mask the effects of loss of Fus. Unlike published fus morphants, maternal zygotic fus mutants do not show motoneuronal degeneration and exhibit normal locomotor activity.
引用
收藏
页码:29 / 35
页数:7
相关论文
共 50 条
  • [1] Rapid Generation Of An In Vivo Loss-Of-Function Genetic Model Of sdhb Zebrafish: Functional And Metabolic Characterization
    Salle, Stefanie Parisien-La
    Nobilleau, Fanny
    Lamontagne, Julien
    Eric, Samarut
    Bourdeau, Isabelle
    JOURNAL OF THE ENDOCRINE SOCIETY, 2024, 8 : A149 - A149
  • [2] Apoc2 loss-of-function zebrafish mutant as a genetic model of hyperlipidemia
    Liu, Chao
    Gates, Keith P.
    Fang, Longhou
    Amar, Marcelo J.
    Schneider, Dina A.
    Geng, Honglian
    Huang, Wei
    Kim, Jungsu
    Pattison, Jennifer
    Zhang, Jian
    Witztum, Joseph L.
    Remaley, Alan T.
    Duc Dong, P.
    Miller, Yury I.
    DISEASE MODELS & MECHANISMS, 2015, 8 (08) : 989 - 998
  • [3] When loss-of-function is loss of function: assessing mutational signatures and impact of loss-of-function genetic variants
    Pagel, Kymberleigh A.
    Pejaver, Vikas
    Lin, Guan Ning
    Nam, Hyun-Jun
    Mort, Matthew
    Cooper, David N.
    Sebat, Jonathan
    Iakoucheva, Lilia M.
    Mooney, Sean D.
    Radivojac, Predrag
    BIOINFORMATICS, 2017, 33 (14) : I389 - I398
  • [4] Loss-of-Function of xpc Sensitizes Zebrafish to Ultraviolet Irradiation
    Liu, Kai
    Sun, Zhaoxiang
    Yang, Chun
    Lo, Li Jan
    Chen, Jun
    FISHES, 2023, 8 (04)
  • [5] Loss-of-function genetic diseases and the concept of pharmaceutical targets
    Laurent Ségalat
    Orphanet Journal of Rare Diseases, 2
  • [6] Loss-of-function genetic screening with shRNA and CRISPR libraries
    Tedesco, Donato
    Makhanov, Mikhail
    Baron, Sylvain
    Suchkov, Dmitry
    Chenchik, Alex
    CANCER RESEARCH, 2015, 75
  • [7] Loss-of-function genetic diseases and the concept of pharmaceutical targets
    Ryan R. Brinkmann
    Marie-Pierre Dubé
    Guy A. Rouleau
    Andrew C. Orr
    Mark E. Samuels
    Nature Reviews Genetics, 2007, 8 : 404 - 404
  • [8] Loss-of-function genetic diseases and the concept of pharmaceutical targets
    L. Ségalat
    Nature Reviews Genetics, 2007, 8 : 404 - 404
  • [9] Loss-of-function genetic diseases and the concept of pharmaceutical targets
    Segalat, L.
    NATURE REVIEWS GENETICS, 2007, 8 (05) : 404 - 404
  • [10] Functional characterization of a FUS mutant zebrafish line as a novel genetic model for ALS
    Bourefis, Annis-Rayan
    Campanari, Maria-Letizia
    Buee-Scherrer, Valerie
    Kabashi, Edor
    NEUROBIOLOGY OF DISEASE, 2020, 142